Global Chiropody & Podiatry Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Chiropody & Podiatry Market Research Report 2024
Chiropodists and podiatrists are medical practitioners, certified or uncertified, those perform the diagnosis, assessment, and treatment of ankles, feet, and rest of the lower legs. They are certified to tend people with arthritis, nail surgery, diabetes, sports injuries, corns, verrucas, etc. Technically chiropodists are not different from podiatrists, the difference in name is as a result of difference in the regional nomenclature of medical practices of Europe and American states. In the U.S they are generally known as podiatrists, whereas in Europe they are known as chiropodists. Their practice segment comprises people of all ages but with the growing complications including diabetes, etc, and wearing joints, the geriatric population forms a majority of the patient segment.
According to MRAResearch’s new survey, global Chiropody & Podiatry market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chiropody & Podiatry market research.
Chiropody & Podiatry have their largest market in the developed nations of North America and Europe, together comprising nearly 2/3rd of the world’s total demand. This was followed by Asia-pacific and rest of the world. Growth is expected in the Asia-Pacific with increased diabetic populations and awareness. Traditional methods of medicine men currently form an equally large practitioner base in many rural parts of South Asia and Africa. Therefore, Asian markets are expected to grow larger than the North American market by the turn of the decade as the average population is comparatively higher.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Chiropody & Podiatry market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Aetna Felt
Integra LifeSciences
Algeo
GILL Podiatry
Henry Scheinetc
Segment by Type
Surgery Practices
Physiotherapy
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chiropody & Podiatry report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Chiropody & Podiatry market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chiropody & Podiatry market research.
Chiropody & Podiatry have their largest market in the developed nations of North America and Europe, together comprising nearly 2/3rd of the world’s total demand. This was followed by Asia-pacific and rest of the world. Growth is expected in the Asia-Pacific with increased diabetic populations and awareness. Traditional methods of medicine men currently form an equally large practitioner base in many rural parts of South Asia and Africa. Therefore, Asian markets are expected to grow larger than the North American market by the turn of the decade as the average population is comparatively higher.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Chiropody & Podiatry market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aetna Felt
Integra LifeSciences
Algeo
GILL Podiatry
Henry Scheinetc
Segment by Type
Surgery Practices
Physiotherapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chiropody & Podiatry report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices